Evidence map›Paper›PMID 32951160›Full record

ArticleJournal of endocrinological investigation2021

Alterations of gut microbiota composition in post-finasteride patients: a pilot study.

F Borgo, A D Macandog, S Diviccaro, E Falvo, S Giatti, G Cavaletti, R C Melcangi

Open access · hybridAbstract read
In one paragraph

Article in Journal of endocrinological investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. The gut-microbiota-brain axis: Focus on gut steroids.Journal of neuroendocrinology · 2025
    Review
  4. Post-finasteride syndrome - a true clinical entity?International journal of impotence research · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Biology · 2023
    Article
  12. The Gut and Skin Microbiome in Alopecia: Associations and Interventions.The Journal of clinical and aesthetic dermatology · 2023
    Review
  13. Gut microbiota and pediatric patients with spina bifida and neurogenic bowel dysfunction.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2023
    Article
  14. Article
  15. Human genital tracts microbiota: dysbiosis crucial for infertility.Journal of endocrinological investigation · 2022
    Review
  16. Article
  17. Article
  18. Gut feelings: the microbiota-gut-brain axis on steroids.American journal of physiology. Gastrointestinal and liver physiology · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

F BorgoDepartment of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
A D MacandogDepartment of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
S DiviccaroDipartimento di Scienze Farmacologiche e Biomolecolari, Università Degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy.
E FalvoDipartimento di Scienze Farmacologiche e Biomolecolari, Università Degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy.
S GiattiDipartimento di Scienze Farmacologiche e Biomolecolari, Università Degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy.
G CavalettiExperimental Neurology Unit, Università di Milano-Bicocca, Monza, Italy.
R C MelcangiDipartimento di Scienze Farmacologiche e Biomolecolari, Università Degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy. roberto.melcangi@unimi.it.ORCID https://orcid.org/0000-0003-0861-8967
University of Milan · ITEuropean Institute of Oncology · ITUniversity of Milano-Bicocca · IT

Funding

MIUR Progetto Eccellenza
6 · The paper itself

Abstract

purposePost-finasteride syndrome (PFS) has been reported in a subset of patients treated with finasteride (an inhibitor of the enzyme 5alpha-reductase) for androgenetic alopecia. These patients showed, despite the suspension of the treatment, a variety of persistent symptoms, like sexual dysfunction and cognitive and psychological disorders, including depression. A growing body of literature highlights the relevance of the gut microbiota-brain axis in human health and disease. For instance, alterations in gut microbiota composition have been reported in patients with major depressive disorder. Therefore, we have here analyzed the gut microbiota composition in PFS patients in comparison with a healthy cohort.

methodsFecal microbiota of 23 PFS patients was analyzed by 16S rRNA gene sequencing and compared with that reported in ten healthy male subjects.

resultsSexual dysfunction, psychological and cognitive complaints, muscular problems, and physical alterations symptoms were reported in more than half of the PFS patients at the moment of sample collection. The quality sequence check revealed a low library depth for two fecal samples. Therefore, the gut microbiota analyses were conducted on 21 patients. The α-diversity was significantly lower in PFS group, showing a reduction of richness and diversity of gut microbiota structure. Moreover, when visualizing β-diversity, a clustering effect was found in the gut microbiota of a subset of PFS subjects, which was also characterized by a reduction in Faecalibacterium spp. and Ruminococcaceae UCG-005, while Alloprevotella and Odoribacter spp were increased compared to healthy control.

conclusionGut microbiota population is altered in PFS patients, suggesting that it might represent a diagnostic marker and a possible therapeutic target for this syndrome.

Indexed as

Drug-Related Side Effects and Adverse ReactionsFinasterideGastrointestinal Microbiome5-alpha Reductase InhibitorsAlopeciaBiodiversityCognitive DysfunctionCorrelation of DataDepressionHumansMaleMiddle AgedPhysical Functional PerformanceRNA, Ribosomal, 16SSequence Analysis, DNASexual Dysfunction, Physiological5-alpha Reductase InhibitorsFinasterideRNA, Ribosomal, 16S5alpha-reductaseAndrogenic alopeciaDepressionFecal microbiotaGut microbiota-brain axisSexual dysfunction

Identifiers

PMID32951160
PMCPMC8124058
OpenAlexW3087137392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.